Brind.

Mikael Dolsten joined the Board of Directors of Arbor Biotechnologies, where Paul Meister is the Chairman.

1 report, 0 independent Updated Jun 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Mikael Dolsten joined the Board of Directors of Arbor Biotechnologies, where Paul Meister is the Chairman.

Who's involved

What this event is mainly about
Mikael DolstenPaul Meister

Keep exploring

The entities involved

  • Mikael Dolsten

    Swedish-American doctor, business executive & corporate director; Chief Scientific Officer, Pfizer

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • Unknown outlet